Health Outcomes Via Positive Engagement in Schizophrenia
NCT04230590 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-09-29
Summary
This is an observational study where digital, clinical and health utilization data are collected from individuals with schizophrenia spectrum disorders who have been recently discharged from a psychiatric hospitalization. The data will be used towards building a model/algorithm capable of monitoring mental health and predicting adverse clinical events, such as relapse and re-admissions.
Conditions
- Schizophrenia Spectrum Disorders
Interventions
- OTHER
-
Observational
Participants will not receive any study intervention. During the 24-week study period, participants will complete five assessment visits and passive digital data from participant's smartphone and study-provided wrist wearable device will be collected.
Sponsors & Collaborators
-
MOH Office for Healthcare Transformation Pte. Ltd.
collaborator UNKNOWN -
Institute of Mental Health, Singapore
lead OTHER
Principal Investigators
-
Jimmy Lee · Institute of Mental Health, Singapore
Eligibility
- Min Age
- 21 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-04
- Primary Completion
- 2023-06-27
- Completion
- 2024-02-29
Countries
- Singapore
Study Locations
More Related Trials
-
Evaluation of Stroop Effect in Patients With Schizophrenia
NCT03163706 ·Status: UNKNOWN ·Phase: NA
-
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
NCT00809731 ·Status: COMPLETED
-
Motivation Skills Training for Schizophrenia
NCT05746455 ·Status: COMPLETED ·Phase: NA
-
AMP SCZ® Observational Study: PREDICT-DPACC
NCT05905003 ·Status: ACTIVE_NOT_RECRUITING
-
Metacognitive Intervention for Individuals With Severe Mental Disorders
NCT05556941 ·Status: COMPLETED ·Phase: NA
-
Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation
NCT05667961 ·Status: COMPLETED
-
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014 ·Status: UNKNOWN
-
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 ·Status: UNKNOWN
-
Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea
NCT01477918 ·Status: UNKNOWN
-
Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics
NCT00569504 ·Status: UNKNOWN
-
Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia
NCT00455663 ·Status: COMPLETED ·Phase: NA
-
SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia
NCT04528095 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia
NCT02874560 ·Status: COMPLETED
-
Effectiveness of Motivation Skills Training (MST)
NCT05805397 ·Status: RECRUITING ·Phase: NA
-
Assessment of Schizophrenia Patients' Clinical Study Experiences
NCT05948111 ·Status: NOT_YET_RECRUITING
-
Study of SPG302 in Adults With Schizophrenia
NCT06442462 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Sustainable Early Episode Clinic Study (SEEC)
NCT03571685 ·Status: COMPLETED ·Phase: NA
-
Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial
NCT03955549 ·Status: COMPLETED ·Phase: PHASE3
-
The Establishment of the Early Intervention Program for Patients With Schizophrenia
NCT00172770 ·Status: UNKNOWN
-
An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder
NCT00861003 ·Status: UNKNOWN
-
Quality of Life in Schizophrenic Patients
NCT00597168 ·Status: COMPLETED
-
Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.
NCT02876900 ·Status: COMPLETED ·Phase: PHASE3
-
Stem Cell Research on Subjects at Genetic High Risk for Schizophrenia
NCT01943175 ·Status: COMPLETED
-
Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE) a Community-Based Cognitive Remediation Trial
NCT06286202 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia
NCT00250575 ·Status: COMPLETED ·Phase: PHASE3